Pharma Penny Stock Under Rs 30: Company Incorporates Subsidiaries in Canada & USA and Approves Fund Raising of Rs 1,500 Crore
Pharma Penny Stock Under Rs 30: Company Incorporates Subsidiaries in Canada & USA and Approves Fund Raising of Rs 1,500 Crore

Pharma Penny Stock Under Rs 30: Company Incorporates Subsidiaries in Canada & USA and Approves Fund Raising of Rs 1,500 Crore

The stock gave multibagger returns of 277 per cent from its 52-week low of Rs 7.71 per share.

DSIJ Intelligence-1 Article rating: 3.5

The stock gave multibagger returns of 277 per cent from its 52-week low of Rs 7.71 per share.

Pharma Penny Stock Under Rs 30: Board to Meet on June 19 to Consider, Evaluate and Approve Proposal of Raising Further Funds
Pharma Penny Stock Under Rs 30: Board to Meet on June 19 to Consider, Evaluate and Approve Proposal of Raising Further Funds

Pharma Penny Stock Under Rs 30: Board to Meet on June 19 to Consider, Evaluate and Approve Proposal of Raising Further Funds

The stock gave multibagger returns of 292 per cent from its 52-week low of Rs 7.35 per share.

DSIJ Intelligence-1 Article rating: 4.2

The stock gave multibagger returns of 292 per cent from its 52-week low of Rs 7.35 per share.

Low PE Pharma Penny Stock Below 60 Rockets Over 10 Per Cent Today with Heavy Volume; Here’s Why!
Low PE Pharma Penny Stock Below 60 Rockets Over 10 Per Cent Today with Heavy Volume; Here’s Why!

Low PE Pharma Penny Stock Below 60 Rockets Over 10 Per Cent Today with Heavy Volume; Here’s Why!

The company has a market cap of over Rs 400 crore and the stock is up by 16.67 per cent from its 52-week low of Rs 49.20 per share.

DSIJ Intelligence-1 Article rating: 5.0

The company has a market cap of over Rs 400 crore and the stock is up by 16.67 per cent from its 52-week low of Rs 49.20 per share.

Promoters hold 65.99 per cent stake: Low PE pharma penny stock below Rs 60; Company announces significant global expansion and strategic integration
Promoters hold 65.99 per cent stake: Low PE pharma penny stock below Rs 60; Company announces significant global expansion and strategic integration

Promoters hold 65.99 per cent stake: Low PE pharma penny stock below Rs 60; Company announces significant global expansion and strategic integration

The company has a market cap of Rs 287 crore and the stock is up by 6 per cent from its 52-week low of Rs 49.20 per share.

DSIJ Intelligence-1 Article rating: 3.3

The shares of the company have a PE of 12x whereas the industry PE is 36x.

From Rs 6.27 to Rs 30.38 per share: Pharma company received certificate of recognition, One Star Export House from Government of India
From Rs 6.27 to Rs 30.38 per share: Pharma company received certificate of recognition, One Star Export House from Government of India

From Rs 6.27 to Rs 30.38 per share: Pharma company received certificate of recognition, One Star Export House from Government of India

The stock gave multibagger returns of 385 per cent from its 52-week low of Rs 6.27 per share.

DSIJ Intelligence-1 Article rating: 3.1

The stock gave multibagger returns of 385 per cent from its 52-week low of Rs 6.27 per share.

Pharma Penny Stock Under Rs 50 Approves FY25 Audited Results; Recommended Rs 0.10 Dividend & Approves Rs 37.22 Cr Acquisition in Trimax Bio Sciences
Pharma Penny Stock Under Rs 50 Approves FY25 Audited Results; Recommended Rs 0.10 Dividend & Approves Rs 37.22 Cr Acquisition in Trimax Bio Sciences

Pharma Penny Stock Under Rs 50 Approves FY25 Audited Results; Recommended Rs 0.10 Dividend & Approves Rs 37.22 Cr Acquisition in Trimax Bio Sciences

From Rs 34.51 per share (52-week low) to Rs 53.59 per share, the stock is up by 55.3 per cent.

DSIJ Intelligence-1 Article rating: 4.0

From Rs 34.51 per share (52-week low) to Rs 53.59 per share, the stock is up by 55.3 per cent.

Low PE pharma penny stock below Rs 60 jumps 14.50 per cent after reporting turnaround net profit of Rs 25 crore in FY25
Low PE pharma penny stock below Rs 60 jumps 14.50 per cent after reporting turnaround net profit of Rs 25 crore in FY25

Low PE pharma penny stock below Rs 60 jumps 14.50 per cent after reporting turnaround net profit of Rs 25 crore in FY25

The company has a market cap of over Rs 300 crore and the stock is up by 16.34 per cent from its 52-week low of Rs 49.20 per share.

DSIJ Intelligence-1 Article rating: 3.4

The company has a market cap of over Rs 300 crore and the stock is up by 16.34 per cent from its 52-week low of Rs 49.20 per share.

2:1 Stock Split: Gujarat-Based Penny Stock Under Rs 2 Hit Upper Circuits as PAT Jumps 14,940 Per Cent in FY25
2:1 Stock Split: Gujarat-Based Penny Stock Under Rs 2 Hit Upper Circuits as PAT Jumps 14,940 Per Cent in FY25

2:1 Stock Split: Gujarat-Based Penny Stock Under Rs 2 Hit Upper Circuits as PAT Jumps 14,940 Per Cent in FY25

The stock is trading at 0.65 times its book value and the stock is up by 36 per cent from its 52-week low of Rs 1.04 per share.

DSIJ Intelligence-1 Article rating: 4.2

The stock is trading at 0.65 times its book value and the stock is up by 36 per cent from its 52-week low of Rs 1.04 per share.

RSS
12345

DALAL STREET INVESTMENT JOURNAL - DEMOCRATIZING WEALTH CREATION

Principal Officer: Mr. Shashikant Singh,
Email: principalofficer@dsij.in
Tel: (+91)-20-66663800

Compliance Officer: Mr. Rajesh Padode
Email: complianceofficer@dsij.in
Tel: (+91)-20-66663800

Grievance Officer: Mr. Rajesh Padode
Email: service@dsij.in
Tel: (+91)-20-66663800

Corresponding SEBI regional/local office address- SEBI Bhavan BKC, Plot No.C4-A, 'G' Block, Bandra-Kurla Complex, Bandra (East), Mumbai - 400051, Maharashtra.
Tel: +91-22-26449000 / 40459000 | Fax : +91-22-26449019-22 / 40459019-22 | E-mail : sebi@sebi.gov.in | Toll Free Investor Helpline: 1800 22 7575 | SEBI SCORES | SMARTODR